Table 4.
Antitubercular activities of lead benzimidazoles
![]() | |||
|---|---|---|---|
| Compound | R1 | R2 | MIC99 (µg/mL) H37Rv |
| SB-P3G2 | 0.63 | ||
| SB-P8B2 | 0.39 | ||
| SB-P17G-C2 | 0.06 | ||
| SB-P17G-C4 | 0.16 | ||
| SB-P20G3 | 0.16 | ||
| SB-P17G-A20 | ![]() |
0.16 | |
| SB-P21G4 | 0.31 | ||
| SB-P21G7 | 0.31 | ||
| SB-P17G-C8 | 0.31 | ||
| SB-P17C-A28 | 0.31 | ||
| SB-P17G-C12 | 0.63 | ||
| SB-P26D2 | ![]() |
0.63 | |


